Skip to main content

Gritstone bio, Inc.

GRTSDelisted Mar 5, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001656634

Gritstone bio, Inc. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on Apr 8, 2025; 56 institutions reported holding it in 13F filings for Q3 2024, worth $20.7M in total; no superinvestor held it.

13F holders, Q3 2021

Institutional positions in Gritstone bio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
92
−9 vs. Q2 2021
Shares held
42.4M
+7.58M (+21.8%) vs. Q2 2021
Total value
$458.4M
+$140.5M (+44.2%) vs. Q2 2021
New holders
12
35 more added
Sold out
21
31 more reduced

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GRTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 92 institutions
Q1 2021: 99 institutionsQ2 2021: 102 institutionsQ3 2021: 92 institutionsQ4 2021: 115 institutionsQ1 2022: 117 institutionsQ2 2022: 87 institutionsQ3 2022: 79 institutionsQ4 2022: 91 institutionsQ1 2023: 91 institutionsQ2 2023: 88 institutionsQ3 2023: 89 institutionsQ4 2023: 88 institutionsQ1 2024: 85 institutionsQ2 2024: 79 institutionsQ3 2024: 56 institutionsQ4 2024: 6 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2021: $458.4M
Q1 2021: $321.1MQ2 2021: $318.2MQ3 2021: $458.4MQ4 2021: $630.0MQ1 2022: $164.9MQ2 2022: $85.1MQ3 2022: $86.0MQ4 2022: $152.1MQ1 2023: $128.6MQ2 2023: $99.5MQ3 2023: $83.6MQ4 2023: $85.9MQ1 2024: $120.4MQ2 2024: $24.2MQ3 2024: $20.7MQ4 2024: $773Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding GRTS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20246$773
Q3 202456$20.7M
Q2 202479$24.2M
Q1 202485$120.4M
Q4 202388$85.9M
Q3 202389$83.6M
Q2 202388$99.5M
Q1 202391$128.6M
Q4 202291$152.1M
Q3 202279$86.0M
Q2 202287$85.1M
Q1 2022117$164.9M
Q4 2021115$630.0M
Q3 202192$458.4M
Q2 2021102$318.2M
Q1 202199$321.1M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Gritstone bio, Inc.; share changes are against Q2 2021.

Institutions holding GRTS in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Copernicus Capital Management, LLC0$00.00%−35,000−100.0%Sold out
Virtu Financial LLC0$00.00%−30,386−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−13,093−100.0%Sold out
Principal Financial Group Inc0$00.00%−11,301−100.0%Sold out
Penn Mutual Asset Management, LLC0$00.00%−10,952−100.0%Sold out
Platform Technology Partners0$00.00%−10,950−100.0%Sold out
ProShare Advisors LLC0$00.00%−10,476−100.0%Sold out
Group One Trading, L.P.0$00.00%−913−100.0%Sold out
Advisory Services Network, LLC0$00.00%−680−100.0%Sold out
Mark Sheptoff Financial Planning, LLC0$00.00%−601−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−500−100.0%Sold out
Sargent Bickham Lagudis LLC0$00.00%−361−100.0%Sold out
Cutler Group LP0$00.00%−300−100.0%Sold out
QS Investors, LLC––––Not filed